Chris- thanks for the link to the 1990 Greenland paper. I had read it some time ago but forgotten about it. It’s just great. Arguably, it would be hard to find another paper that speaks so directly to the question at the heart of this thread. I’ll have to read it several more times to understand it properly, but I think that the effort will be worthwhile.
I see what Suhail is saying here; this ostensible inconsistency has caught my attention as well.
At first glance, it appears that Dr.Greenland’s views might have changed over the years. Several of his earlier papers highlight that confidence intervals presented in observational studies are difficult (if not impossible) to interpret given the absence of random sampling or randomization. Those papers propose that confidence intervals, if presented in the observational context, should be viewed as reflecting the “minimum” degree of uncertainty in the point estimate- a scenario that would only exist if some very unrealistic conditions were in play (e.g., random sampling, which doesn’t occur in clinical observational research). In recent years, however, it appears (to me at least) that his emphasis has shifted. Now, instead of emphasizing the importance of being adequately restrained when interpreting observational study results, he seems to emphasize the importance of not being overly restrained. Specifically, he’s talked a lot in recent years about the perils of “nullism” (i.e., the tendency to disregard potential therapeutic harm signals simply because their confidence intervals cross the null).
It’s challenging to reconcile this apparent shift in focus over time; but, at my own peril, I’ll take a shot at trying to explain it. I expect that top epidemiology experts are acutely aware that many decades of recklessly over-interpreted observational research, churned out by under-qualified researchers, has resulted in few people taking observational evidence seriously these days. And so, in an effort to move the pendulum back in the other direction, he is now cautioning research consumers about the risk of adopting an overly nihilistic view of observational evidence (i.e., disregarding point estimates that could reflect potentially important public health effects, but which lie within confidence intervals that cross the null). Given his apparent agreement, back in 1995, regarding the challenges inherent in interpreting small relative effects (https://www.science.org/doi/pdf/10.1126/science.7618077), I find his more recent exhortations to avoid under-interpreting small effects a bit hard to understand…
A couple of quotes from the 1995 article:
“As a result, most epidemiologists interviewed by Science said they would not take seriously a single study reporting a new potential cause of cancer unless it reported that exposure to the agent in question increased a person’s risk by at least a factor of 3-which is to say it carries a risk ratio of 3. Even then, they say, skepticism is in order unless the study was very large and extremely well done and biological data support the hypothesized link. Sander Greenland, a University of California, Los Angeles, epidemiologist, says a study reporting a twofold increased risk might then be worth taking seriously-“but not that seriously.”
But later:
“There’s nothing sinful about checking for confounding variables. The sin comes in believing a causal hypothesis is true because your study came up with a positive result, or believing the opposite because your study was negative."
While his earlier papers seem to focus on the first listed “sin” (i.e., believing a causal hypothesis is true…), his primary concern in more recent years seems to be reflected in the bolded phrase.
While maybe agreeing in theory with the bolded phrase, many clinicians will disagree with it in practice. Any suggestion, in clinical journals or the media, that clinicians should “act” on weak, uncertain potential harm signals acknowledges only the numerator in the the therapeutic risk/benefit ratio. Epidemiologists rush to trumpet the numerator in spite of the fact that they are not trained to understand the denominator. But it’s the ratio that clinicians need to consider when advising their patients. And those who don’t deeply understand the ratio are in no position to provide clinical advice.